Apolipoprotein E gene polymorphism and colorectal cancer: Gender-specific modulation of risk and prognosis

Clinical Science

Volumn 104, Issue 5, 2003, Pages 537-545

  Watson, Mark A ^a   Gay, Laura ^b   Stebbings, William S L ^a   Speakman, Chris T M ^a   Bingham, Sheila A ^b   Loktionov, Alexandre ^b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Apolipoprotein E; Colorectal cancer; Gene polymorphism; Risk factor

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE;

AGED; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; POLYMORPHISM, GENETIC; PROGNOSIS; RISK; SEX FACTORS; SMOKING;

EID: 0038017246     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20020329     Document Type: Article

References (56)

1. Vineis, P., Malats, N., Lang, M. et al. (eds) (1999) Metabolic polymorphisms and susceptibility to cancer, IARC Sci. Publ. 148
2. Potter, J. D. (1999) Colorectal cancer: Molecules and populations. J. Natl. Cancer Inst. 91, 916-932
3. Bartsch, H. (2000) Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. Mutat. Res. 462, 255-279
4. Rock, C. L., Lampe, J. W. and Patterson, R. E. (2000) Nutrition, genetics, and risks of cancer. Annu. Rev. Public Health 21, 47-64
5. Woutersen, R. A., Appel, M. J., van Gardenen-Hoetmer, A. and Wijnands, M. V. W. (1999) Dietary fat and carcinogenesis. Mutat. Res. 443, 111-127
6. Lipkin, M., Reddy, B., Newmark, H. and Lamprecht, S. A. (1999) Dietary factors in human colorectal cancer. Annu. Rev. Nut. 19, 545-586
7. Sugimura, T. (2000) Nutrition and dietary carcinogens. Carcinogenesis 21, 387-395
8. Dammerman, M. and Breslow, J. L. (1995) Genetic basis of lipoprotein disorders. Circulation 91, 505-512
9. Galton, D. G. (1997) Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications. Clin. Chim. Acta 257, 181-197
10. Mahley, R. W. and Rall, S. C. (2000) Apolipoprotein E: Far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1, 507-537
11. Mahley, R. W. (1988) Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240, 622-630
12. Wilson, P. F., Myers, R. H., Larson, M. G., Ordovas, J. M., Wolf, P. A. and Schaefer, E. J. (1994) Apolipoprotein E, dyslipidemia and coronary heart disease. The Framingham Offspring Study. JAMA, J. Am. Med. Sci. 272, 1666-1671
13. Kesäniemi, Y. A., Ehnholm, C. and Miettinen, T. A. (1987) Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J. Clin. Invest. 80, 578-581
14. Van Erpecum, K. J. and Carey, M. C. (1996) Apolipoprotein E4: another risk factor for cholesterol gallstone formation? Gastroenterology 111, 1764-1767
15. Ros, E. (2000) Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk. Atherosclerosis 151, 357-379
16. Kervinen, K., Södervik, H., Mäkelä, J. et al. (1996) Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology 110, 1785-1790
17. Davidson, N. O. (1996) Apolipoprotein E polymorphism: Another player in the genetics of colon cancer susceptibility? Gastroenterology 110, 2006-2009
18. Hallman, D. M., Boerwinkle, E., Saha, N. et al. (1991) The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49, 338-349
19. Butler, W. J., Ryan, P. and Roberts-Thomson, I. C. (2001) Metabolic genotypes and risk for colorectal cancer. J. Gastroenterol. Hepatol. 16, 631-635
20. Katan, M. B. (1986) Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet i, 507-508
21. Vogel, T., Guo, N.-H., Guy, R. et al. (1994) Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J. Cell. Biochem. 54, 299-308
22. 1 phase. J. Biol. Chem. 273, 20156-20161
23. Paka, L., Goldberg, I. J., Obunike, J. C. et al. (1999) Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. J. Biol. Chem. 274, 36403-36408
24. Couffinhal, T., Silver, M., Kearney, M. et al. (1999) Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE(-/-) mice. Circulation 99, 3188-3198
25. Haapala, K., Lehtimäki, T., Ilvekoski, E. and Koivlsto, P. A. (2000) Apolipoprotein E genotype is not linked to locally recurrent hormone-refractory prostate cancer. Prostate Cancer Prostatic Dis. 3, 107-109
26. Liestol, K., Kvittingen, E. A., Rootwelt, H. et al. Association between apolipoprotein E genotypes and cancer risk in patients with acquired immunodeficiency syndrome. Cancer Detect. Prev. 24, 496-499
27. Moysich, K. B., Freudenheim, J. L., Baker, J. A. et al. (2000) Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk. Mol. Carcinogenesis 27, 2-9
28. Zunarelli, E., Nicoll, J. A. R., Migaldi, M. and Trentini, G. P. (2000) Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome. Breast Cancer Res. Treatment 63, 193-198
29. Wessel, N., Liestol, K., Maehlen, J. and Brorson, S. H. (2001) The apolipoprotein E epsilon 4 allele is not risk factor for prostate cancer in the Norwegian population. Br. J. Cancer 85, 1418
30. Atkin, W. S., Hart, A., Edwards, R. et al. (1998) Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 42, 560-565
31. Loktionov, A., Bingham, S. A., Vorster, H., Jerling, J. C., Runswick, S. A. and Cummings, J. H. (1998) Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br. J. Nutr. 79, 133-139
32. Loktionov, A., Watson, M. A., Gunter, M., Stebbings, W. S. L., Speakman, C. T. M. and Bingham, S. A. (2001) Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: Interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis 22, 1053-1060
33. Day, N., Oates, S., Luben, R. et al. (1999) EPIC Norfolk: study design and characteristics of the cohort. Br. J. Cancer 80 (Suppl. 1), 95-103
34. Winawer, S. J., Fletcher, R. H., Miller, L. et al. (1997) Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 112, 594-642
35. Turnbull, R. B., Kyle, K., Watson, F. B. and Spratt, J. (1967) Cancer of the colon: The influence of the no-touch isolation technic on survival rates. Ann. Surg. 166, 420-427
36. Loktionov, A., Vorster, H., O'Neill, I. K. et al. (1999) Apolipoprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans. Atherosclerosis 145, 125-135
37. Loktionov, A., Scollen, S., McKeown, N. and Bingham, S. A. (2000) Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E ε4-carrying free-living individuals. Br. J. Nutr. 84, 885-890
38. McMichael, A. J., Jensen, O. M., Parkin, D. M. and Zaridze, D. G. (1984) Dietary and endogenous cholesterol and human cancer. Epidemiol. Rev. 6, 192-216
39. Nomura, A. M. Y., Stemmermann, G. N. and Chyou, P.-H. (1991) Prospective study of serum cholesterol levels and large-bowel cancer. J. Natl. Cancer Inst. 83, 1403-1407
40. Kreger, B. E., Anderson, K. M., Schatzkin, A. and Splansky, G. L. (1992) Serum-cholesterol level, body-mass index, and the risk of colon cancer - The Framingham Study. Cancer 70, 1038-1043
41. Kritchevsky, S. B. (1992) Dietary lipids and the low blood cholesterol-cancer association. Am. J. Epidemiol. 135, 509-520
42. Epstein, F. H. (1992) Low serum-cholesterol, cancer and other noncardiovascular disorders. Atherosclerosis 94, 1-12
43. Parkin, D. M., Whelan, S. L., Ferlay, J., Raymond, L. and Young, J. (eds) (1997) Cancer incidence in five continents, vol. VII, IARC Sci. Publ. 143
44. Fernandez, E., Bosetti, C., La Vecchia, C., Levi, F., Fioretti, F. and Negri, E. (2000) Sex differences in colorectal cancer mortality in Europe, 1955-1996. Eur. J. Cancer Prev. 9, 99-104
45. Rex, D. K. (1995) Colonoscopy: A review of its yield for cancer and adenomas by indication. Am. J. Gastroenterol. 90, 353-365
46. Chu, K. C., Tarone, R. E., Chow, W.-H., Hankey, B. F. and Ries, L. A. G. (1994) Temporal patterns in colorectal cancer: Incidence, survival and mortality from 1950 through 1990. J. Natl. Cancer Inst. 86, 997-1006
47. Franceschi, S., Gallus, S., Talamini, R., Tavani, A., Negri, E. and La Vecchia, C. (2000) Menopause and colorectal cancer. Br. J. Cancer 82, 1860-1862
48. Garry, P. J., Baumgartner, R. N., Brodie, S. G. et al. (1999) Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E. Clin. Chem. 45, 1214-1223
49. Mahley, R. W., Pepin, J., Palaoglu, K. E., Malloy, M. J., Kane, J. P. and Bersot, T. P. (2000) Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype. J. Lipid Res. 41, 1290-1301
50. Ng, M. K. C., Jessup, W. and Celermajer, D. S. (2001) Sex-related differences in the regulation of macrophage cholesterol metabolism. Curr. Opin. Lipidol. 12, 505-510
51. Shinomiya, S., Sasaki, J., Kiyohara, C. et al. (2001) Apolipoprotein E genotype, serum lipids, and colorectal adenomas in Japanese men. Cancer Lett. 164, 33-40
52. Frikke-Schmidt, R., Nordestgaard, B. G., Agerholm-Larsen, B., Schnohr, P. and Tybjaerg-Hansen, A. (2000) Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J. Lipid Res. 41, 1812-1822
53. McKeown-Eyssen, G. (1994) Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol. Biomarkers Prev. 3, 687-695
54. Bruce, W. R., Giacca, A. and Medline, A. (2000) Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 9, 1271-1279
55. de Kok, T. M. C. M. and van Maanen, J. M. S. (2000) Evaluation of fecal mutagenicity and colorectal cancer risk. Mutat. Res. 463, 53-101
56. Jacobs, D., Blackburn, H., Higgins, M. et al. (1992) Report on the conference on low blood cholesterol-mortality associations. Circulation 86, 1046-1060